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Local reference ranges for full blood count and CD4 
lymphocyte count testing
Denise Lawrie, Lindi Marie Coetzee, Piet Becker, Johnny Mahlangu, Wendy Stevens, Deborah Kim Glencross
Reference intervals are critically important for the correct 
interpretation of diagnostic tests. The full blood count and 
CD4 count are two frequently performed tests in HIV-
endemic settings such as Gauteng province, South Africa. 
Haemoglobin concentration is an independent prognostic 
indicator in HIV, while CD4 count determines initiation and 
response to antiretroviral (ARV) treatment.1 The South African 
National Health Laboratory Services (NHLS) establishes 
reference ranges with the implementation of new tests, and 
periodically re-assesses reference intervals to accommodate 
changes in population demographics as well as technological 
advancements (ISO 15189:2003 guidelines Point 5.5.5).2 As 
differences in altitude, endemic disease and ethnic differences 
influence reference intervals, other reference intervals are not 
necessarily pertinent to the Gauteng region.
Few studies from southern Africa address the region’s ethnic 
and geographical diversity.3-5 The results of three published 
full blood count reference ranges since 1980 are summarised 
in Table I. The studies were performed on clinically healthy, 
predominantly black subjects. Although largely similar, there 
were some differences between these reference ranges and 
those obtained in Caucasian subjects, such as the reference 
ranges by Mendelow et al. (unpublished data, 1985) that 
are currently used in the NHLS, Gauteng region. Although 
haematology reference ranges were established for the black 
population of the Witwatersrand in 1987,3 these were never 
implemented by the NHLS (previously the South African 
Institute for Medical Research) because of constraints in the 
laboratory information system at the time.
Full blood count analyser technologies have developed 
rapidly over the last 20 years. For example, platelet counts 
were not routinely available and were done on a separate 
instrument; this is illustrated by the absence of platelet 
reference ranges reported for Lesotho in 19834 and the Cape 
Peninsula in 1995 (Table I).5 Automated methods have replaced 
manual methods, e.g. white cell differential and reticulocyte 
counts. New parameters, such as red cell distribution width 
(RDW) and mean platelet volume (MPV) are routinely 
available on automated full blood count analysers, giving 
supplementary clinical and technical information at no 
additional cost. Because these are new parameters, local 
reference intervals were not available at the time and published 
intervals were therefore used.6 Original impedance counting 
and sizing methods have been enhanced or replaced by optical 
methods, yielding new information, e.g. granulocytes are 
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Objective. Recent advances in full blood count and CD4 
technology, coupled with the changing population 
demographics of the Gauteng region, have necessitated re-
evaluation of the reference ranges currently in use.
Methods. A cross-sectional study of 631 female and 88 male 
HIV-negative participants from the Gauteng region was 
performed. Full blood count, automated differential and CD4 
count analyses were done using the latest internationally 
accepted technology. Reference ranges were compiled from 
the 2.5th and 97.5th percentiles for both male and female 
participant groups, and gender and ethnic comparisons 
calculated by non-parametric tests.
Results. Results of 41 females were removed from the 
statistical analysis because their results were suggestive 
of possible anaemia. Full blood count reference interval 
comparison confirmed gender-specific differences in red 
blood cell and platelet parameters. Ethnic-specific differences 
were found for some red blood cell parameters in the black 
female cohort. In addition, black males and females both 
generally had lower neutrophil and higher lymphocyte counts 
than a combined Asian/Caucasian/coloured ethnic group.
Conclusion. Comparison of the currently calculated reference 
ranges with published data and reference values in use 
indicated that a separate ethnic-specific reference range 
should be introduced for the percentage/absolute neutrophil 
count and percentage lymphocytes. In addition, locally 
derived reference ranges for red cell distribution width 
(RDW) and CD4 percentage of lymphocytes should be 
implemented for routine diagnostic testing.
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counted using their peroxidase content. Red blood cell and 
white blood cell maturation is automatically categorised. Such 
improvements in full blood count analyser technology have 
resulted in better overall linearity and precision of results.
Absolute CD4 count reference intervals were established in 
Gauteng in 1992 using a dual platform (DP) full blood count/
flow cytometry method.7 Subsequently, DP methods were 
replaced by single platform (SP) methods combining white cell 
count analyses with absolute CD4 counting by flow cytometry 
alone. The SP PanLeucoGating CD4 method was introduced 
into the NHLS in 2002 as the routine CD4 testing method; it 
has improved accuracy, precision and reproducibility of CD4 
testing.8,9 Although a recent multi-centre study10 showed no 
significant differences between DP and SP analyses, it is still 
necessary to verify the current absolute CD4 count reference 
range to exclude any DP bias.
The aim of our study was to validate current NHLS reference 
ranges for the Gauteng region for full blood count and absolute 
CD4 lymphocyte counts in the face of technological advances 
and shifting population demographics. In addition, a reference 
interval for the CD4 percentage of lymphocytes needed to be 
established.
Materials and methods
Ours was a cross-sectional study performed on 631 female 
and 88 male HIV-negative, clinically healthy volunteers from 
the Gauteng region;11 63% of the female group, and 56% of 
the male group, were black, with an average age of 41 for all 
participants. Inclusion criteria were HIV negativity and general 
well-being. No exclusions were made on the basis of a history 
of smoking or contraceptive use, adverse clinical findings, or 
presence of co-morbid diseases such as TB and hepatitis.12
The University of the Witwatersrand Human Ethics 
Committee approved the study. The laboratory where the 
study was conducted is certified in terms of the South African 
National Accreditation System.13
After giving informed consent, each volunteer donated a 
single venous blood sample collected into dipotassium EDTA 
Table I. Summary of local South African haematological reference ranges published after 1980
Parameter   Maseru, Lesotho4   Witwatersrand3                 Cape Peninsula5
RBC (1012/l)
Male    4.49 - 5.90    4.43 - 6.03    3.2 - 5.8
Female    3.85 - 5.25    4.07 - 5.13    3.0 - 5.3
HGB (g/dl)
Male    13.7 - 17.8    13.8 - 17.9    10.3 - 16.7
Female    11.7 - 16.0    12.4 - 15.5    9.0 - 15.2
HCT (l/l) 
Male    0.41 - 0.52    0.39 - 0.51    0.31 - 0.525
Female    0.35 - 0.47    0.36 - 0.45    0.273 - 0.472
MCV (fl) 
Male    81 - 99    77 - 94    82 - 110.4
Female            76.2 - 106.7
MCH (pg)
Male    27.2 - 33.6    27.5 - 33.3    25.3 - 34.9
Female            24.8 - 33.8
MCHC (g/dl)
Male    32.1 - 35.5    33.4 - 37.0    29.9 - 36.0
Female            30.3 - 35.4
Platelets (109/l)
Male        164 - 396
Female        191 - 442
WBC (109/l)
Male    2.53 - 8.43    3.4 - 9.3    3.7 - 12.6
Female    2.90 - 9.10 
Neutrophils (109/l)   0.958 - 6.403   1.96 - 6.52    2.9 - 7.1
Lymphocytes (109/l)
Male    1.012 - 2.972   0.95 - 3.38    2.1 - 6.0
Female    0.840 - 3.256
Monocytes (109/l)   0.082 - 0.607   0.05 - 0.08    0.17 - 0.75
Eosinophils (109/l)   0 - 0.276    0 - 0.36    0.14 - 1.56
Basophils (109/l)       0 - 0.05
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(BD Vacutainer Systems, Plymouth, UK). The samples were 
stored at 20±2ºC prior to preparation and analysis. All testing 
was completed within 12 hours of collection. 
Full blood counts were done on the Beckman Coulter LH 
750 Hematology Analyzer (Beckman Coulter, Fullerton, CA, 
USA). Samples were examined for the following parameters: 
total white blood cell count (WBC) and 5-part automated 
differential count, red blood cell count (RBC), haemoglobin 
(HGB), haematocrit (HCT), mean cell volume (MCV), mean 
cell haemoglobin (MCH), mean cell haemoglobin concentration 
(MCHC), RDW, platelet count (PLT) and MPV.
SP absolute CD4 counts and the percentage CD4 of 
lymphocytes were obtained using a lyse-no-wash procedure. 
Samples were stained using the Beckman Coulter Flowcare 
PLG CD4 reagent kit with Flow Count fluorospheres and 
analysed on a Beckman Coulter XL-MCL Flow Cytometer.
The accuracy of the full blood count and CD4 values 
was subject to strict internal and external quality assurance 
procedures. The laboratory participates in the Beckman Coulter 
Interlaboratory Quality Assessment Program (IQAP), and the 
NHLS National Quality Assessment programmes for full blood 
count and CD4 monitoring; it also takes part in the United 
Kingdom National External Quality Assessment Scheme 
(UKNEQAS), African Regional External Quality Assessment 
Scheme (AFREQAS) for CD4 monitoring, and Royal College of 
Pathologists of Australia Quality Assessment Programme for 
the automated full blood count and white differential counts.
Statistical analysis
The guidelines for reference interval determination of the 
Clinical Laboratory Standards Institute (CLSI, Wayne, PA, 
USA) were followed.14 Although these guidelines are meant for 
establishing new reference intervals, the basic principles also 
apply to re-assessment of reference ranges.
Of the 631 female participants, 41 females were removed 
from statistical analyses because their full blood count results 
were suggestive of anaemia (HGB <12 g/dl and MCV <80 
fl);15 this may have skewed the data. All data sets were tested 
for normal distribution using the Kolmogorov-Smirnov (KS) 
and Shapiro-Wilk tests of normality. The 2.5th and 97.5th 
percentiles were used as reference intervals as the data were 
normally distributed. Differences between genders were 
calculated with the non-parametric Mann-Whitney U-test, 
and differences between all ethnic groups within the male 
and female populations analysed using the Kruskal-Wallis 
test. A combined gender-specific Asian-coloured-Caucasian 
group was compared with the corresponding gender-specific 
black population. Data analysis was performed using StatCorp 
2003 (Stata Statistical Software: Release 8.0. Stata Corporation, 
College Station, Tex., USA) and GraphPad Prism 5 Software 
(GraphPad Software, La Jolla, CA, USA).
Results
Tables II and III summarise the calculated reference intervals 
for full blood count and CD4 lymphocyte parameters obtained 
from this study, alongside the reference ranges currently in 
use in Gauteng NHLS laboratories. There were significant 
differences between male and female participants (p<0.001) for 
some parameters (Tables II and III, column 2). Ethnic-specific 
differences were noted for some parameters between the black 
participants and the combined Asian/Caucasian/coloured 
participants (Table IV, column 3).
Discussion
The opportunity to perform this validation presented itself 
when a large-scale Human Sciences Research Council (HSRC) 
study was undertaken to assess HIV prevalence among health 
care workers.11 This study allowed data collection from a more 
representative demographic population with a broader age 
distribution than is currently encompassed by the full blood 
count reference ranges used in the NHLS Gauteng region.
Red blood cell parameters
An interesting finding of our current study was a decreased 
upper limit of HGB for males of 17.5 g/dl v. 18.3 g/dl in the 
1985 study. A possible explanation for this finding is that there 
were fewer participants who smoked than in the 1985 study. 
Smoking increases HGB values. The upper limit for the female 
participant group did not increase.
Gender-specific differences
Significant differences were noted between males and females 
for RBC, HGB, HCT, MCV, MCH, MCHC and RDW (Table 
II). These findings are in keeping with those of previous 
South African studies.3-5,16 The gender differences in red blood 
cell indices and HGB are historically attributed to biological 
and physiological fluctuations, including menstrual blood 
loss, hormonal influences of oestrogens and testosterone on 
erythropoiesis, and the prevalence of iron deficiency anaemia 
in women.3,17
Ethnic differences
Ethnic differences were noted in red blood cell parameters 
in the female subjects, in keeping with previous southern 
African studies.3,16 In the current study, black females had 
lower red cell counts, HGB and HCT values in general (Table 
IV). Although it may not be necessary to establish separate 
reference intervals for these parameters, the ranges for RBC, 
HGB, and HCT documented for black females fell at the lower 
end of the current reference intervals. Automated ‘canned 
comment’ reporting may suffice to highlight such findings to 
attending clinicians. No ethnic differences were noted for male 
participants regarding red blood cell parameters.
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Table II. Comparison of the reference ranges from this study with the current reference ranges used in NHLS laboratories for 
haematology parameters
Parameter New ranges from this study  Mann-Whitney p-value (male v. female)  Currently in use
RBC (1012/l)
Male   4.19 - 5.85        <0.0001***   4.89 - 6.11
Female   3.93 - 5.40        4.13 - 5.67
HGb (g/dl)
Male   13.4 - 17.5        <0.0001***   14.3 - 18.3
Female   11.6 - 16.4        12.1 - 16.3
HCT (l/l)
Male   0.39 - 0.51        <0.0001***   0.43 - 0.55
Female   0.34 - 0.48        0.37 - 0.49
MCV (fl)
Male   83.1 - 101.6       <0.05*    79.1 - 98.9
Female   78.9 - 98.5        79.1 - 98.9
MCH (pg)
Male   27.8 - 34.8        <0.001**   27.0 - 32.0
Female   26.1 - 33.5        27.0 - 32.0
MCHC (g/dl)
Male   33.0 - 35.0        <0.0001***   32.0 - 36.0
Female   32.7 - 34.9        32.0 - 36.0
RDW (%)
Male   12.1 - 16.3        <0.001**   11.6 - 14.0
Female   12.4 - 17.3        11.6 - 14.0
Platelets (109/l)
Male   171 - 388        <0.0001***   137 - 373
Female   186 - 454        178 - 400
MPV (fl)
Male   7.1 - 11.0        NS    7.0 - 11.4
Female   7.3 - 11.3        7.0 - 11.4
WBC (109/l)
Male   3.92 - 10.40       NS    3.92 - 9.88
Female   3.90 - 12.60       3.92 - 9.88
Neutrophils (109/l)
Male   1.6 - 6.98        NS    2.0 - 7.5
Female   1.6 - 8.3
Lymphocytes (109/l)
Male   1.4 - 4.2        <0.05*    1.0 - 4.0
Female   1.4 - 4.5
Monocytes (109/l)
Male   0.3 - 0.8        <0.05*    0.18 - 0.8
Female   0.2 - 0.8
Eosinophils (109/l)
Male   0 - 0.95        NS    0 - 0.45
Female   0 - 0.4
Basophils (109/l)
Male   0 - 0.1        NS    0 - 0.2
Female   0 - 0.1
% neutrophils
Male   32 - 76        NS    51 - 76
Female   34 - 72
% lymphocytes
Male   18 - 56         NS    26 - 40
Female   21 - 56
% monocytes
Male   4 - 12        <0.0001***   5 - 8
Female   3 - 10
% eosinophils
Male   0 - 8        <0.05*    0 - 5
Female   0 - 6
% basophils
Male   0 - 2        NS    0 - 2
Female   0 - 1
p-values indicate significant differences between male and female participants for each parameter tested; NS indicates no significant differences. 
* p=0.01 - 0.05.  
** p=0.001 - 0.01.  
*** p<0.001.
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Platelet parameters
Studies of differences in platelet counts between gender 
groups consistently report higher values in females, regardless 
of ethnicity.3,18 Gender differences in platelet counts have 
historically been attributed to hormonal influences.3 In the 
current study, similar differences were observed (Table II). 
No ethnic differences were demonstrated. No gender- or 
ethnic- specific differences were found in the MPV volume. No 
significant difference in the MPV volume was found between 
the reference interval determined in this study and the global 
reference interval (7 - 11.4 fl).6
White blood cell parameters
Previous southern African studies have shown gender- and 
ethnic-specific differences in total WBCs.3,16 The present study 
did not show any significant gender differences, but confirmed 
ethnic differences in total WBCs between the black participants 
and other ethnic groups (Tables II and IV).
Significant ethnic differences were found for some types 
of white blood cells. The absolute and percentage neutrophil 
counts were generally lower, and the percentage lymphocytes 
generally higher, in black participants (Table IV), resulting in 
wider reference intervals.
Table III. Comparison of the reference ranges from this study compared with the current reference ranges used in the NHLS 
laboratories for CD4 parameters
Parameter   This study       Mann-Whitney p-value (males v. females)               In use
CD4 absolute count (106/l)                     500 - 2 010
Male    503 - 1 807
Female    561 - 2 051   <0.0001***
CD4 % of lymphocytes                Not currently reported
Male    27.7 - 56.7   
Female    31.6 - 58.0    <0.0001***
p-values indicate significant differences between male and female participants; NS indicates no significant difference.
* p=0.01 - 0.05.  
** p=0.001 - 0.01.  
*** p<0.001.
Table IV. Summary of the significant differences noted in reference intervals between the black population group and the 
remaining combined ethnic groups (Asian, coloured and Caucasian)
             Combined Asian, coloured  
Parameter  Black ethnic group         and Caucasian ethnic groups        Significance
RBC (female)  3.89 - 5.32          4.02 - 5.59          p<0.0001***
HGB (female)  11.6 - 16.1          11.6 - 16.8          p<0.0001***
HCT (female)  0.34 - 0.47          0.35 - 0.50          p<0.0001***
RDW (female)  12.5 - 17.3          12.3 - 17.2          p<0.0001***
Eosinophils (female) 0 - 0.4          0 - 0.5          p<0.05*
WBC 
Male   3.93 - 10.04         4.49 - 10.74          p<0.001**
Female   3.8 - 11.40          4.68 - 13.84          p<0.0001***
Neutrophils 
Male   1.46 - 6.40          2.14 - 7.49          p<0.0001***
Female   1.53 - 7.27          2.04 - 8.96          p<0.0001***
% neutrophils 
Male   31 - 72          42 - 81          p<0.0001***
Female   32 - 72          35 - 74          p<0.0001***
Monocytes 
Male   0.2 - 0.7          0.3 - 0.9          p<0.01**
Female   0.2 - 0.8          0.2 - 0.9          p<0.0001***
% lymphocytes 
Male   21 - 58.0          14 - 47          p<0.0001***
Female   23 - 57          19 - 54          p<0.0001***
NS indicates no significant difference.
* p=0.01 - 0.05. 
** p=0.001 - 0.01. 
*** p<0.001.
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The current study confirmed ethnic differences in absolute 
monocyte counts reported elsewhere.18 This finding in black 
participants is not clinically significant though interesting, as it 
was noted previously and may reflect the impact of improved 
sensitivity in automated monocyte counting.19
The differences in white blood cell differential reference 
intervals found between ethnic groups in the southern African 
population correlate with published data from other parts 
of Africa, the UK and the USA.3,16,18,20,21 When comparing 
the full blood count and absolute differential counts with 
reference interval data from the rest of Africa that used similar 
methodology, our reported reference intervals for the Gauteng 
region showed the closest similarity to intervals reported for 
Uganda.21
CD4 values
Our gender-specific differences for the CD4 percentage of 
lymphocytes and absolute CD4 lymphocyte counts (Table 
III) concur with those in other African, Asian and European 
countries.22 However, we found no significant ethnic 
differences in these figures.
Conclusion
Our study confirmed that, in general, the NHLS’s full 
blood count reference ranges for Gauteng (Mendelow et al., 
unpublished data, 1985 and Tikly et al.,3 1987) and the CD4 
ranges established in 19927 compare well with the current 
study and other recently reported ranges from Europe and 
Africa. Current reference intervals therefore remain valid 
for use in the Gauteng region, with some modifications as 
suggested below for optimisation.
The reference intervals currently in use for red cell 
parameters accommodate the differences found between males 
and females for RBC, HGB, HCT, MCV, MCH and MCHC. 
However, we recommend that the current reference intervals 
for RDW (11.6 - 14%) be amended to reflect our findings (12.1 - 
16.3% for males; 12.4 - 17.3% for females). Amending the RDW 
reference ranges would result in changes in commenting on red 
cell morphology. It is anticipated that if our recommendations 
are adopted, fewer ‘red cell anisocytosis’ comments would be 
noted on otherwise normal full blood count reports.
The current NHLS gender-specific platelet reference ranges 
for males and females remain applicable. A single reference 
range for MPV is still valid, and the intervals currently in use 
are adequate.
With ethnic differences noted in some types of white blood 
cells, it is recommended that a separate reference range is 
introduced for percentage and absolute neutrophil counts and 
percentage lymphocytes for black patients. This modification 
would reduce the number of patients ‘misdiagnosed’ with 
neutropenia, as well as erroneous reporting of reversed 
neutrophil/lymphocyte ratios.
The current absolute CD4 reference range is robust enough 
to accommodate the differences described in this paper, and 
the CD4 percentage reference interval established in this study 
should be implemented. With minor changes and additions to 
current reference intervals for full blood counts and absolute 
CD4 testing, these ranges will be more representative of the 
current patient demographics in Gauteng province and the 
updated technology in use at NHLS laboratories.
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